Royal Fund Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-7
| Closed | – | – | 290 |
|
|
2020
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 616 |
|
|
2019
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 649 |
|
|
2019
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 605 |
|
|
2019
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 579 |
|
|
2019
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 610 |
|
|
2018
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 605 |
|
|
2018
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 564 |
|
|
2018
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 582 |
|
|
2018
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 585 |
|
|
2017
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 655 |
|
|
2017
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 478 |
|
|
2017
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 463 |
|
|
2017
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 435 |
|
|
2016
Q4 | $0 | Buy |
+7
| New | – | ﹤0.01% | 393 |
|